Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten

7680670640015 CH-67064 J05AR02 08.03.0.

Active substances:

Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten
Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten
Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten
1 / 3
google

Details

Product number
6706401
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
abacavirum 600 mg, lamivudinum 300 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carboxymethylamylum natricum A, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, polysorbatum 80, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 3.276 mg.

Articles (1)

Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/02/2024
Patient information leaflet
Français
23/02/2024
Patient information leaflet
Italien
23/02/2024
Professional SmPC
Allemand
23/02/2024
Professional SmPC
Français
23/02/2024
Professional SmPC
Italien
23/02/2024

Detailed composition

Substance Quantity Type Category
abacavirum
600.0 MG Substance Wirkstoff (Principe actif)
lamivudinum
300.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
carboxymethylamylum natricum A
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 4000
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
natrium
3.276 MG Substance HBESI

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
67064
Drug name
Abacavir-Lamivudin-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
J05AR02
Authorization status
Z
Dispensation category
A
First authorization
04/07/2018
Authorization expiration date
01/10/2026
IT number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektion

Packaging details

Description (FR)
ABACAVIR LAMIVUDIN Mepha Lactab 600/300mg 30 pce
Description (DE)
ABACAVIR LAMIVUDIN Mepha Lactab 600/300mg 30 Stk
Market launch
04/07/2018
Market withdrawal
29/06/2026
Narcotic (BTM)
No

Available generics

Abacavir Lamivudin Sandoz, Filmtabletten
CHF 268.95
View
Buy us a coffee Explore the data